Research programme: lysosomal storage disease therapeutics - ArmaGen Technologies

Drug Profile

Research programme: lysosomal storage disease therapeutics - ArmaGen Technologies

Alternative Names: AGT-183; AGT-184; HIRMAb-ASA fusion protein - ArmaGen Technologies; IgG-ASA fusion protein - ArmaGen Technologies; Recombinant N-sulphoglucosamine sulphohydrolase - ArmaGen Technologies; Recombinant sulfamidase - ArmaGen Technologies

Latest Information Update: 04 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ArmaGen Technologies
  • Developer ArmaGen Technologies; Department of Veterans Affairs; Saint Louis University; University of California at Los Angeles; University of Texas Medical Branch
  • Class Arylsulfatases; Enzymes; Immunoglobulin fusion proteins; Monoclonal antibodies
  • Mechanism of Action Arylsulfatase replacements; Enzyme replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Metachromatic leukodystrophy; Mucopolysaccharidosis III

Most Recent Events

  • 04 Jul 2016 Preclinical development is ongoing for Mucopolysaccharidosis III and Metachromatic leukodystrophy in USA (ArmaGen Technologies pipeline, July 2016)
  • 25 Dec 2012 Preclinical trials in Metachromatic leukodystrophy in USA (IV) before December 2012
  • 29 Apr 2008 Preclinical trials in Mucopolysaccharidosis III in USA (IV) before April 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top